(Reuters) -German medical technology company Siemens Healthineers on Thursday reported first-quarter revenue slightly above consensus, as its U.S. revenues increased by 16% while those from China declined 6% due to "continued delays in customer orders". Like its healthcare technology sector peers, Siemens Healthineers has been struggling against a Chinese anti-corruption campaign that launched July 2023. With hospitals scaling back equipment ordering, growth in the firm's third largest market, Asia Pacific and Japan, has been dampened from the effects. The company's first-quarter group revenue landed at 5.48 billion euros ($5.69 billion), rising 5.9% from a year earlier and higher than the…